Details of the Drug Reposition

General Information of This Drug (ID: DM9SY8E)

Drug Name
PT630   DM9SY8E
Drug Type
Peptide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colon cancer DISVC52G 2B90.Z Preclinical [1]
Lung cancer DISCM4YA 2C25.0 Preclinical [1]
------------------------------------------------------------------------------------

References

1 Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009 Dec;119(12):3613-25.